Report Top-Line CLASSIC Trial Results in mid 2016
Initiate Phase III in AAV by end of 2016
Report Early Results from Pancreatic Cancer Trial H1 2016 and initial PFS results in 2H 2016
CCX354: Rheumatoid Arthritis/Myeloma Bone Metastasis (CCR1)
Explore Partnering Options to Advance Program in IBD
CCR1 CCX354 Completed Phase IIa
Progress in TH17 Disease
* also known as CCX282 or Traficet-EN.